MEI Pharma Inc (MEIP)
3.92
+0.06
(+1.55%)
USD |
NASDAQ |
Mar 27, 16:00
3.95
+0.03
(+0.77%)
After-Hours: 20:00
MEI Pharma Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
March 31, 2021 | 95.01% |
December 31, 2020 | 96.08% |
September 30, 2020 | 92.33% |
June 30, 2020 | 98.02% |
March 31, 2020 | 30.87% |
December 31, 2019 | 36.41% |
September 30, 2019 | 40.54% |
June 30, 2019 | 2.48% |
March 31, 2019 | 6.89% |
December 31, 2018 | 50.73% |
Date | Value |
---|---|
September 30, 2018 | -102.7% |
June 30, 2018 | -102.0% |
March 31, 2018 | -114.8% |
December 31, 2017 | -103.4% |
September 30, 2017 | -118.4% |
June 30, 2017 | -120.0% |
March 31, 2017 | 74.54% |
December 31, 2016 | 89.70% |
September 30, 2016 | 0.18% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
2.48%
Minimum
Jun 2019
98.02%
Maximum
Jun 2020
55.40%
Average
40.54%
Median
Sep 2019
Gross Profit Margin (Quarterly) Benchmarks
Merck & Co Inc | 73.26% |
United Therapeutics Corp | 88.45% |
Macrogenics Inc | 98.22% |
Voyager Therapeutics Inc | -- |
Moderna Inc | 66.97% |